AVRAnteris Technologies Global Corp.
8.890USD+4.53%Mkt Cap: 863.43M USDP/E: Last update: 2026-06-01

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel …

Indicators:|

Key Statistics

Company
Market Cap863.43M USD
Enterprise Value560.09M USD
Revenue (TTM)1.85M USD
Gross Profit1.38M USD
Net Income (TTM)-95.30M USD
Revenue/Share0.0380 USD
Last Price8.890 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees174
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-8.80
PEG
EV/EBITDA-5.93
EV/Revenue302.59
P/S453.32
P/B3.01
EPS (TTM)-2.22
EPS (Forward)-0.98
52W Range
2.85087% of range9.790
52W High9.790 USD
52W Low2.850 USD
Profitability
Gross Margin74.28%
Oper. Margin-4859.72%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-59.21%
ROA-33.99%
Growth
Revenue Growth-11.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-34.63M USD
CapEx (TTM)2.39M USD
FCF Margin-2844.73%
FCF Yield-6.10%
Net Debt-278.96M USD
Net Debt/EBITDA2.95
Balance Sheet
Debt/Equity0.09
Current Ratio20.93
Quick Ratio20.66
Book Value/Sh2.864 USD
Cash/Share2.904 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)16.00 USD
Target Range15.00 USD18.00 USD
# Analysts4
Ownership
Shares Out.97.34M
Float78.60M
Insiders16.49%
Institutions66.02%
Short Interest
Short Ratio5.7d
Short % Float6.15%
Short % Out.4.30%
Shares Short4.19M
Short (prev mo.)4.13M
Technical
SMA 506.343 (+40.1%)
SMA 2005.299 (+67.8%)
Beta0.59
S&P 52W Chg27.94%
Avg Vol (30d)909.38K
Avg Vol (10d)1.51M
Technical Indicators
RSI (14)63.3
MACD0.7917
MACD Signal0.6697
MACD Hist.+0.1220
BB Upper9.901 USD
BB Middle7.525 USD
BB Lower5.149 USD
BB Width63.15%
ATR (14)0.5185 USD
Vol Ratio (20d)0.47x